Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Claral
2. Nerisona
3. Nerisone
4. Nerisone Forte
5. Temetex
1. 59198-70-8
2. Diflucortolone 21-valerate
3. Diflucortolone Valerate [jan]
4. Nerisona
5. [2-[(6s,8s,9r,10s,11s,13s,14s,16r,17s)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Pentanoate
6. Nerisone
7. Temetex
8. Texmeten
9. 1a63z067c8
10. Afusona
11. Dsstox_cid_28524
12. Dsstox_rid_82796
13. Dsstox_gsid_48598
14. Difluocortolone Valerianate
15. Difluocortolone Valerate
16. Cas-59198-70-8
17. Diflucortolonevalerate
18. Diflucortolonvalerianat
19. Diflucortolonvalerianat [german]
20. Einecs 261-655-8
21. Brn 2030579
22. Unii-1a63z067c8
23. Ncgc00183100-01
24. Afusona (tn)
25. Diflucortolon Valerate
26. Schembl3015
27. 6-alpha,9-difluoro-11-beta-hydroxy-16-alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione
28. 6-alpha,9-difluoro-11-beta-hydroxy-21-valeryloxy-16-alpha-methyl-1,4-pregnadiene-3,20-dione
29. 6alpha,9-difluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-valerate
30. Chembl2358130
31. Diflucortolone Valerate (jp17)
32. Dtxsid1048598
33. Chebi:31484
34. Zinc4212943
35. Tox21_112929
36. Hy-u00058
37. S5414
38. Diflucortolone Valerate Assay Standard
39. Akos015901782
40. Tox21_112929_1
41. Ccg-269528
42. Diflucortolone Valerate [mart.]
43. Diflucortolone Valerate [who-dd]
44. Diflucortolone Valerate Impurity Standard
45. Diflucortolone 21-valerate [mi]
46. Ncgc00263574-01
47. Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16-methyl-21-((1-oxopentyl)oxy)-, (6-alpha,11-beta,16-alpha)-
48. Cs-0021944
49. D01764
50. E86978
51. 198d708
52. Q-200986
53. Q10860261
Molecular Weight | 478.6 g/mol |
---|---|
Molecular Formula | C27H36F2O5 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 478.25308057 g/mol |
Monoisotopic Mass | 478.25308057 g/mol |
Topological Polar Surface Area | 80.7 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 943 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
28
PharmaCompass offers a list of Diflucortolone Valerate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diflucortolone Valerate manufacturer or Diflucortolone Valerate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diflucortolone Valerate manufacturer or Diflucortolone Valerate supplier.
PharmaCompass also assists you with knowing the Diflucortolone Valerate API Price utilized in the formulation of products. Diflucortolone Valerate API Price is not always fixed or binding as the Diflucortolone Valerate Price is obtained through a variety of data sources. The Diflucortolone Valerate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Travazol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Travazol, including repackagers and relabelers. The FDA regulates Travazol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Travazol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Travazol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Travazol supplier is an individual or a company that provides Travazol active pharmaceutical ingredient (API) or Travazol finished formulations upon request. The Travazol suppliers may include Travazol API manufacturers, exporters, distributors and traders.
click here to find a list of Travazol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Travazol DMF (Drug Master File) is a document detailing the whole manufacturing process of Travazol active pharmaceutical ingredient (API) in detail. Different forms of Travazol DMFs exist exist since differing nations have different regulations, such as Travazol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Travazol DMF submitted to regulatory agencies in the US is known as a USDMF. Travazol USDMF includes data on Travazol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Travazol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Travazol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Travazol Drug Master File in Japan (Travazol JDMF) empowers Travazol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Travazol JDMF during the approval evaluation for pharmaceutical products. At the time of Travazol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Travazol suppliers with JDMF on PharmaCompass.
Travazol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Travazol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Travazol GMP manufacturer or Travazol GMP API supplier for your needs.
A Travazol CoA (Certificate of Analysis) is a formal document that attests to Travazol's compliance with Travazol specifications and serves as a tool for batch-level quality control.
Travazol CoA mostly includes findings from lab analyses of a specific batch. For each Travazol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Travazol may be tested according to a variety of international standards, such as European Pharmacopoeia (Travazol EP), Travazol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Travazol USP).